Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives-Reference-Cited by-同舟云学术

Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives

Published:2018-05 Issue: Volume:66 Page:104-113
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Taieb Julien,Moehler Markus,Boku Narikazu,Ajani Jaffer A.,Yañez Ruiz Eduardo,Ryu Min-Hee,Guenther Silke,Chand Vikram,Bang Yung-Jue

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference84 articles.

1. Immunotherapy for gastroesophageal cancer;Goode;J Clin Med,2016

2. International Agency for Research on Cancer. GLOBOCAN 2012: cancer incidence, mortality and prevalence worldwide in 2012, http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx; 2013 [accessed 05.12.17].

3. Current status of novel agents in advanced gastroesophageal adenocarcinoma;Kothari;J Gastrointest Oncol,2015

4. American Cancer Society. Key statistics for stomach cancer, https://www.cancer.org/cancer/stomach-cancer/about/key-statistics.html; 2016 [accessed 05.12.17].

5. Comprehensive molecular characterization of gastric adenocarcinoma;Cancer Genome Atlas research network;Nature,2014

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A machine learning-based radiomics model for prediction of tumor mutation burden in gastric cancer;Frontiers in Genetics;2023-11-06

2. Eventos adversos reumatológicos secundarios al uso de inhibidores de punto de control inmunitario;Reumatología Clínica;2023-04

3. Rheumatological adverse events secondary to immune checkpoint inhibitors;Reumatología Clínica (English Edition);2023-04

4. Unexpected curative effect of PD-1 inhibitor in gastric cancer with brain metastasis: A case report;Frontiers in Oncology;2023-02-16

5. Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis;Frontiers in Oncology;2023-01-26